Skip to main content


ADL Biopharma
Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, is pleased to announce that it has completed a 12m€ capital increase in ADL Biopharma (“ADL”) and has become the sole shareholder of the Spanish biopharmaceutical company, which focuses on the development and production of pharma APIs and specialty ingredients for the food, flavour and fragances markets.